Simon Lowth, Interim Chief Executive Officer at AstraZeneca, comments on the results. AZ’s core EPS target range for the full year is expected to maintain at US$5.85 to $6.15. This is largely ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Simon Shuster is a senior correspondent at TIME. He covers international affairs, with a focus on Russia and Ukraine. For his first book, The Showman, he reported inside the Ukrainian President ...

U.S. Secretary of State Marco Rubio will visit Israel and Arab states in mid-February, a State Department official said, making his first trip to the Middle East after a widely condemned proposal ...

we are taking another significant step towards reducing our carbon footprint and supporting the UK’s transition to a greener future,” said Simon Lowth, Chief Financial Officer, BT Group.

Taoiseach Simon Harris has said, after fake adverts with his image flooded X in recent days. Mr Harris has appeared to threaten legal action against Elon Musk after false adverts of news articles ...

I DON'T FIND my story unique. It’s simple: I had bad habits and vices. Over time, I became depressed, overweight, and unmotivated. In early March 2020, Crohn's disease came close to taking my life.

AstraZeneca, said: "Our company delivered a very strong performance in 2024 with Total Revenue and Core EPS up 21% and 19% respectively. We also delivered nine positive high value Phase III ...

Investors with a lot of money to spend have taken a bullish stance on AstraZeneca AZN. And retail traders should know. We noticed this today when the positions showed up on publicly available ...

The government has defended its negotiations with AstraZeneca, after the pharmaceutical giant ditched a planned £450m investment last week, blaming a shortfall in government funding. Science ...

AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool, blaming a cut in funding from government. The investment, announced last year in the Tories' spring budget ...

On Thursday, AstraZeneca Plc AZN reported fourth-quarter sales of $14.89 billion, up 18% year over year (+19% at constant currency), beating the consensus of $14.29 billion. The company's adjusted ...